By: Rose Duesterwald
Researchers discovered a version of the Cas protein that fits into adeno-associated viruses (AAVs). This virus can be engineered to deliver targeted
Rose Duesterwald is a journalist who writes for Patient Worthy, focusing on medical research and advancements in the field of healthcare. She covers a wide range of topics, including rheumatoid arthritis, gene therapy, neurodegenerative diseases, and cancer treatments. With a passion for science and a dedication to providing accurate and informative articles, Rose aims to bring awareness to important medical breakthroughs and their impact on patients' lives.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Rose's coverage predominantly focuses on medical research, cancer treatment, neurological disorders, drug development and clinical trials. She often cites data and uses press releases as sources for her articles.
For reaching out to Rose Duesterwald, consider providing access to new medical research findings or clinical trial results. Experts in the fields of oncology, neurology, pharmacology or other related specialties who can provide insights into the latest developments in these areas would likely capture her attention. Additionally, professionals with access to relevant data that could contribute to a deeper understanding of the topics covered may also find success when approaching Rose with pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .